Bioxodes is a clinical-stage biotech company developing therapeutics for patients with (thrombo)inflammatory diseases.

Joined June 2019
22 Photos and videos
22 Jan 2025
Excited to announce Bioxodes will attend #ISC2025 (Feb 5–7)! Valérie Pireaux will present preclinical data on BIOX-101, targeting intracerebral hemorrhage — an unmet need in stroke care. Let’s connect at ISC! 🚀 #StrokeCare #Innovation #Bioxodes #ISC2025
1
36
13 Nov 2024
Full house @BrainDays ! Our CMO, Dr. Hans Warrinnier, delivered a high-impact pitch on BIOX-101 at #BrainInnovationDays, highlighting our solution for unmet medical needs. Honored to be selected to pitch & showcase a poster among top innovators! #BIOX101 #strokecare #Bioxodes
18
28 Oct 2024
Very much looking forward to attending the @BrainDays and to share our innovation through a poster presentation! Let's meet in Brussels and talk about brain health. #voiceofstroke #ICH #strokecare
19
Bioxodes SA retweeted
16 May 2024
Replying to @bioxodes
@bioxodes receives European Patent Office intention to grant patent, offering lead asset broad protection in thromboinflammation. tinyurl.com/35ch8vwu
1
2
73
17 Apr 2024
#BioEquity 2024 is just around the corner! @EBDgroup @BioCentury Our CEO is looking forward to present Bioxodes' progress and vision to potential investors. See you in San Sebastian! #Bioxodes #BioEquity24
42
20 Feb 2024
Exciting news! Our CEO, Marc Dechamps, will be sharing latest updates on BIOX-101 (Ir-CPI), our groundbreaking therapy for intracerebral hemorrhage on several conferences. bioxodes.com/newsroom/press-… #EITSummit #Sachs_ELSF #LSXWorld #BioEquity
2
77
Our CEO Marc Dechamps will be presenting at the upcoming #biotechshowcase in #SanFrancisco ! Curious to hear more about our latest developments? See you there! @EBDgroup #JPMorgan
54
27 Oct 2023
Prepping for #bioeurope, our CEO Marc Dechamps is all set for #partnering! Our mission to advance healthcare solutions for #stroke is stronger than ever! #IrCPI @EBDgroup
63
23 Aug 2023
Proud to share that our CEO Marc Dechamps, has been awarded with the 'Biotechnology CEO of the Year - Europe' title at the 2023 Business Worldwide Magazine CEO Awards! 🏆 Full PR prnewswire.com/news-releases…
4
92
27 Jun 2023
🌟 Exciting Update! We presented our groundbreaking research on Ir-CPI at #ISTH2023. Revolutionizing #thrombosis treatment and #neuroinflammation! @isth HealthcareInnovation #Bioxodes
2
137
30 May 2023
Last week, @bioxodes  was in Munich, Germany, to attend the 9th European Stroke Organization Conference (#ESOC2023). Valérie Pireaux, Preclinical Scientist, presented data on Ir-CPI in a model of intracerebral hemorrhage. You can view the poster here: 🧠 lnkd.in/eCZnrmsP

1
1
208
24 May 2023
Part of Bioxodes' team is attending #ESOC2023. 👉 Reach us if you want to know more about our drug candidate Ir-CPI in intracerebral haemorrhage. You can also consult our e-poster on-site
1
3
272
24 May 2023
Yesterday our Clinical Project Manager Charlotte Corbisier did a great job presenting at #ESOTA! She explained our approach, as a small biotech company, to a phase IIa trial on Ir-CPI. Stay tuned for more news coming soon! #stroke #strokeprevention #voiceofstroke #ESOC2023
1
75
12 May 2023
Join us at the #ESOC2023 organised by @ESOstroke! The @bioxodes team will give multiple presentations on our lead candidate #Ir-CPI and the important progress we made since inception! #stroke #brainthrombosis #neuroinflammation
1
2
251
Bioxodes SA retweeted
[ALA Client News] @bioxodes presents latest developments at key international conferences - on first-in-class drug candidate for patients with intracerebral hemorrhage 👉ala.associates/events/bioxod… @BioCentury @ESOstroke @isth #conferences #BioEquity2023 #ESOC2023 #ISTH2023
2
2
188
26 Apr 2023
PRESS RELEASE Interesting times for @bioxides! Meet us at the following conferences @BioEquity @EBDgroup @isth @esocstroke PR: ala.associates/events/bioxod…
2
3
381